NCT00369863View on ClinicalTrials.gov

A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

June 30, 2003

Conditions

Diabetic Macular Edema

Interventions

DRUG

Triamcinolone acetonide

Trial Locations (1)

16666

Labbafinejad Medical Center, Tehran

All Listed Sponsors

lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT00369863 - A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema | Biotech Hunter | Biotech Hunter